| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-12 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |